News & Insights

Cases & Deals

August 19, 2020

Evolent Health Issues $117 Million of Convertible Senior Notes in Exchange Offer and Private Placement

King & Spalding advised Evolent Health, Inc. on its $117.0 million privately negotiated exchange and private placement with certain holders of its outstanding 2.00% Convertible Senior Notes due 2021 and certain new investors to exchange $84.2 million aggregate principal amount of the 2021 Notes for $84.2 million aggregate principal amount of 3.50% Convertible Senior Notes due 2024 and an aggregate cash payment of $2.5 million, and issue $32.8 million aggregate principal amount of New Notes for cash at par. Evolent also entered into agreements with holders of 2021 Notes to repurchase an aggregate $14.0 principal amount of 2021 Notes. 

Evolent delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable.  Evolent’s solutions encompass total cost of care management, specialty care management, and administrative simplification. 

Capital Markets